Skip to main content
Log in

Glycosylation ofα 1 glycoprotein in septic shock: Changes in degree of branching and in expression of sialyl Lewisx groups

  • Glycosylation and Disease Papers
  • Published:
Glycoconjugate Journal Aims and scope Submit manuscript

Abstract

The occurrence of differences in acute-phase response, with respect to concentration and glycosylation of α1-acid glycoprotein (AGP) was studied in the sera of patients surviving or not from septic shock. Crossed affino-immunoelectrophoresis was used with concanavalin A andAleuria aurantia lectin for the detection of the degree of branching and fucosylation, respectively, and the monoclonal CSLEX-1 for the detection of sialyl Lewisx (SLeX) groups on AGP. Septic shock apparently induced an acute-phase response as indicated by the increased serum levels and changed glycosylation of AGP. In the survivor group a transient increase in diantennary glycan content was accompanied by a gradually increasing fucosylation and SLeX expression, comparable to those observed in the early phase of an acute-inflammatory response. Remarkably, in the non-survivor group a modest increase in diantennary glycan content was accompanied by a strong elevation of the fucosylation of AGP and the expression of SLeX groups on AGP, typical for the late phase of an acute-phase response. Our results suggest that these changes in glycosylation of AGP can have a prognostic value for the outcome of septic shock.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

AAL:

Aleuria aurantia lectin

AGP:

α1-acid glycoprotein

CAIE:

crossed affinoimmunoelectrophoresis

Con A:

Concanavalin A

HSPC:

human serum protein calibrator

IL-1:

interleukin 1

IL-6:

interleukin 6

LIF:

leukaemia inhibitory factor

LPS:

lipopolysaccharide

SLeX:

sialyl Lewisx

TNF:

tumour necrosis factor

References

  1. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RMH, Sibbald WJ (1992)Chest 101: 1644–55.

    Google Scholar 

  2. Giroir BP (1993)Crit Care Med 21: 780–89.

    Google Scholar 

  3. Hack CE, De Groot ER, Felt-Bersma RJ, Nuijens JH, Strack Van Schijndel RJM, Eerenberg-Belmer AJM, Thijs LG, Aarden LA (1989)Blood 74: 1704–10.

    Google Scholar 

  4. Patel RT, Deen KI, Youngs D, Warwick J, Keighley MRB (1994)Br J Surg 81: 1306–8.

    Google Scholar 

  5. Villers D, Dao T, Nguyen J-M, Bironneau E, Godard A, Moreau M, De Groote D, Nicolas F, Soulillou J-P, Anegon I (1995)J Infect Dis 171: 232–36.

    Google Scholar 

  6. Libert C, Brouckaet P, Fiers W (1994)J Exp Med 180: 1571–75.

    Google Scholar 

  7. Schmid K, Nimberg RB, Kimura A, Yamaguchi H, Binette JP (1977)Biochim Biophys Acta 492: 291–302.

    Google Scholar 

  8. van Dijk W, Havenaar EC, Brinkman-van der Linden ECM (1995)Glycoconjugate J 12: 227–33.

    Google Scholar 

  9. Mackiewicz A, Marcinkowska-Pieta R, Ballou S, Mackiewicz S, Kushner I (1987)Arthritis Rheum 30: 513–18

    Google Scholar 

  10. Pawlowski T, Mackiewicz SH, Mackiewicz A (1989)Arthritis Rheum 32: 347–51.

    Google Scholar 

  11. Mackiewicz A, Pawlowski T, Mackiewicz-Pawlowska A, Wiktorowicz K, Mackiewicz S (1987)Clin Chim Acta 163: 185–90.

    Google Scholar 

  12. Wells C, Bøg-Hansen TC, Cooper EH, Glass MR (1981)Clin Chim Acta 109: 59–67.

    Google Scholar 

  13. Raynes J (1982)Biomedicine 36: 77–86.

    Google Scholar 

  14. De Graaf TW, van der Stelt ME, Angergen MG, van Dijk W (1993)J Exp Med 177: 657–66.

    Google Scholar 

  15. van der Linden ECM, de Graaf TW, van der Stelt ME, Anbergen MG, van Dijk W (1993)Glycoconjugate J 10: 316–17.

    Google Scholar 

  16. de Graaf TW, van Ommen ECR, van den Stelt ME, Kerstens PJSM, Boerbooms AMT, van Dijk W (1994)J Rheum 21: 2209–16.

    Google Scholar 

  17. Mancini G, Carbonara AO, Heremans JF (1965)Ummunochemistry 2: 235–54.

    Google Scholar 

  18. Bøg-Hansen TC (1973)Anal Biochem 56: 480–88.

    Google Scholar 

  19. Dargan E, Thompson S, Cantwell BMJ, Wilson RG, Turner GA (1994)Glycosyl & Dis 1: 37–43.

    Google Scholar 

  20. Van der Linden ECM, de Graaf TW, Anbergen MG, Dekker RM, van Ommen ECR, van den Eijnden DH, van Dijk W (1994)Glycosyl & Dis 1: 45–52.

    Google Scholar 

  21. Hao YL, Wickerhauser M (1973)Biochim Biophys Acad 322: 99–108.

    Google Scholar 

  22. Baumann H, Gauldie J (1994)Immunol today 15: 74–80.

    Google Scholar 

  23. Bennet M, Schmid K (1980)Proc Natl Acad Sci 77: 6109–13.

    Google Scholar 

  24. Pos O, Oostendorp RAJ, van der Stelt ME, Scheper RJ, van Dijk W (1990)Inflammation 14: 133–41.

    Google Scholar 

  25. Bories PN, Feger J, Benbernou N, Rouzeau J-D, Agneray J, Durand G (1990)Inflammation 14: 315–23.

    Google Scholar 

  26. Costello M, Fiedel BA, Gewurz H (1979)Nature 281: 677–78.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brinkman-Van Der Linden, E.C.M., Van Ommen, E.C.R. & Van Dijk, W. Glycosylation ofα 1 glycoprotein in septic shock: Changes in degree of branching and in expression of sialyl Lewisx groups. Glycoconjugate J 13, 27–31 (1996). https://doi.org/10.1007/BF01049676

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01049676

Keywords

Navigation